1. Home
  2. FSBC vs MLYS Comparison

FSBC vs MLYS Comparison

Compare FSBC & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FSBC
  • MLYS
  • Stock Information
  • Founded
  • FSBC 2002
  • MLYS 2019
  • Country
  • FSBC United States
  • MLYS United States
  • Employees
  • FSBC N/A
  • MLYS N/A
  • Industry
  • FSBC Banks
  • MLYS Biotechnology: Pharmaceutical Preparations
  • Sector
  • FSBC Finance
  • MLYS Health Care
  • Exchange
  • FSBC Nasdaq
  • MLYS Nasdaq
  • Market Cap
  • FSBC 618.7M
  • MLYS 590.3M
  • IPO Year
  • FSBC 2021
  • MLYS 2023
  • Fundamental
  • Price
  • FSBC $32.58
  • MLYS $11.87
  • Analyst Decision
  • FSBC Buy
  • MLYS Strong Buy
  • Analyst Count
  • FSBC 3
  • MLYS 2
  • Target Price
  • FSBC $32.33
  • MLYS $30.00
  • AVG Volume (30 Days)
  • FSBC 46.0K
  • MLYS 255.3K
  • Earning Date
  • FSBC 10-28-2024
  • MLYS 11-11-2024
  • Dividend Yield
  • FSBC 2.45%
  • MLYS N/A
  • EPS Growth
  • FSBC N/A
  • MLYS N/A
  • EPS
  • FSBC 2.25
  • MLYS N/A
  • Revenue
  • FSBC $113,173,000.00
  • MLYS N/A
  • Revenue This Year
  • FSBC N/A
  • MLYS N/A
  • Revenue Next Year
  • FSBC $20.05
  • MLYS N/A
  • P/E Ratio
  • FSBC $14.46
  • MLYS N/A
  • Revenue Growth
  • FSBC N/A
  • MLYS N/A
  • 52 Week Low
  • FSBC $21.10
  • MLYS $6.06
  • 52 Week High
  • FSBC $35.13
  • MLYS $16.91
  • Technical
  • Relative Strength Index (RSI)
  • FSBC 58.21
  • MLYS 41.32
  • Support Level
  • FSBC $31.79
  • MLYS $11.30
  • Resistance Level
  • FSBC $33.98
  • MLYS $13.06
  • Average True Range (ATR)
  • FSBC 0.98
  • MLYS 1.01
  • MACD
  • FSBC -0.03
  • MLYS -0.22
  • Stochastic Oscillator
  • FSBC 55.35
  • MLYS 14.43

About FSBC Five Star Bancorp

Five Star Bancorp is a California state-chartered non-member bank. The Company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking three or more antihypertensive medications typically including a diuretic.

Share on Social Networks: